CD101, CD101 molecule, 9398

N. diseases: 15; N. variants: 2
Disease: Systemic candidiasis ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0153252
Disease: Systemic candidiasis
Systemic candidiasis 		0.030 Biomarker disease BEFREE Rezafungin (CD101) is a novel echinocandin antifungal agent currently in clinical development for the treatment of candidemia and invasive candidiasis. 29555631 2018
CUI: C0153252
Disease: Systemic candidiasis
Systemic candidiasis 		0.030 Biomarker disease BEFREE CD101 is currently being evaluated as a once-weekly intravenous (i.v.) infusion for the treatment of candidemia and invasive candidiasis. 29133552 2018
CUI: C0153252
Disease: Systemic candidiasis
Systemic candidiasis 		0.030 Biomarker disease BEFREE CD101, a novel echinocandin with a long plasma half-life and enhanced stability, is in development for once-weekly IV administration for the treatment of candidemia and invasive candidiasis. 28826987 2017